|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-2-23
|
|
pubmed:abstractText |
In patients receiving intracoronary stents, stent thrombosis is reduced when ticlopidine therapy is combined with aspirin after the procedure. However, ticlopidine causes neutropenia in 1% of patients when administered for >2 weeks, and little is known about the duration that ticlopidine needs be administered to prevent stent thrombosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
19
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-53
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9892591-Adult,
pubmed-meshheading:9892591-Aged,
pubmed-meshheading:9892591-Aged, 80 and over,
pubmed-meshheading:9892591-Antibodies, Monoclonal,
pubmed-meshheading:9892591-Coronary Disease,
pubmed-meshheading:9892591-Drug Administration Schedule,
pubmed-meshheading:9892591-Endosonography,
pubmed-meshheading:9892591-Enoxaparin,
pubmed-meshheading:9892591-Female,
pubmed-meshheading:9892591-Humans,
pubmed-meshheading:9892591-Immunoglobulin Fab Fragments,
pubmed-meshheading:9892591-Male,
pubmed-meshheading:9892591-Middle Aged,
pubmed-meshheading:9892591-Myocardial Infarction,
pubmed-meshheading:9892591-Neutropenia,
pubmed-meshheading:9892591-Platelet Aggregation Inhibitors,
pubmed-meshheading:9892591-Prospective Studies,
pubmed-meshheading:9892591-Safety,
pubmed-meshheading:9892591-Stents,
pubmed-meshheading:9892591-Thrombosis,
pubmed-meshheading:9892591-Ticlopidine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement.
|
|
pubmed:affiliation |
Division of Cardiovascular Diseases, Department of Internal Medicine and the Section of Biostatistics, Mayo Clinic, Rochester, MN, USA. berger.peter@mayo.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
